Abstract
Our aim was to study skin remodeling and autoantibody production in an experimental model of scleroderma (SSc), following nasal tolerance with human type V collagen (Col V). Female New Zealand rabbits (n = 12) were immunized with two doses of 1 mg/ml of Col V in complete Freund’s adjuvant and additional two boosters in incomplete Freund’s adjuvant to induce SSc. After 150 days, half of these immunized rabbits were submitted to type V collagen-induced tolerance receiving a daily nasal administration of 25 μg of Col V. Control animals (n = 6) were only submitted to type V collagen-induced tolerance. Serial skin biopsies were performed on days 0, 150 and 210, and stained with H&E, Masson’s trichrome and Picrosirius for morphological and morphometric analysis. Types I, III and V collagen were identified by immunofluorescence. The animals’ serum samples were collected to determine anti types I, III, IV and V collagen and antinuclear antibodies (ANA). Skin biopsies from immunized animals confirmed SSc morphology as previously described, such as progressive decrease of papillary dermis, appendages atrophy, increased type I, III and V collagen deposition. Rabbits with Col V-induced nasal tolerance showed reduction of skin involvement, with significant decrease of collagen amount. Humoral immune response did not change with nasal tolerance. Collagen V nasal tolerance promotes regression of skin remodeling process in an experimental model of SSc. We suggest that nasal tolerance with type V collagen can be a promising therapeutic option to treat scleroderma patients.
Similar content being viewed by others
References
Abraham DJ, Varga J (2005) Scleroderma: from cell and molecular mechanisms to disease models. Autoimmunity Spec Iss 26(11):587–595
Akbari O, Dekruyff RH, Umetsu DT (2001) Pulmonary dentritic cells producing IL-10 mediate tolerance induced by respiratory expore to antigen. Nat Immun 2:725–731
Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, Leroy EC, Fritzler MJ (1996) Autoantibodies to fibrillarin in systemic sclerosis (scleroderma): an immunogenetic, serologic, and clinical analysis. Arthritis Rheum 39:1151–1160
Artlett CM, Cox LA, Jimenez SA (2000) Detection of cellular microchimerism of male origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens. Arthritis Rheum 43:1062–1066
Bell SA, Faust H, Mittermuller J, Kolb HJ, Meurer M (1996) Specificity of antinuclear antibodies in scleroderma-like graft versus host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 134:848–854
Bezerra MC, Teodoro WR, Oliveira CC, Velosa APP, Ogido LTI, Gauditano G, Parra ER, Capelozzi VL, Yoshinari NH (2006) Scleroderma-like remodelling induced by type V collagen. Arch Dermatol Res 298(2):51–57
Clark SH (2005) Animal models in SSc. Rheumatol Rep 7:150–155
Faria AMC, Weiner H (1999) Oral tolerance: mechanisms and therapeutic applications. Advanc Immunol 73:153–264
Haque MA, Myzobuchi T, Yasufuku K, Fujisawa T, Brutkiewiez RR, Zeng Y, Woods K, Smith GN, Cummings OW, Heidler KM, Wilkes DS (2002) Evidence for immune responses to a self antigen in lung transplantation: role of type V collagen-specific T-cells in the pathogenesis of lung allograft rejection. J Immunol 169:1542–1549
Jimenez SA, Batuman O (1993) Immunopathogenesis of systemic sclerosis: possible role of retroviruses. Autoimmunity 16:225–233
Jonuleit H, Schmitt E (2003) The regulatory T-cell family: distinct subsets and their interrelations. J Immunol 171(12):6323–6327
Kodera T, McGaha TL, Phelps R, Paul WE, Bona CA (2002) Disrupting the IL-4 gene rescues mice homozygous for the tight-skin mutation from embryonic death and diminishes TGF-β production by fibroblasts. Proc Natl Acad Sci USA 99:3800–3805
Kuwana M, Kaburaki J, Okano Y, Inako H, Tsuji K (1993) The HLA_DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 92:1296–1301
Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18:816–827
Mares DC, Heidler KM, Smith GN, Cummings OW, Harris ER, Foreman BH, Wilkes DS (2000) Type V collagen modulates alloantigen-induced pathology and immunology in the lung. Am J Respir Cell Mol Biol 23:62–70
Mayne R, Burgeson R (1993) Structure and function of collagen types. In: Ulecham R (ed) Biology of extracellular matrix, 20th edn., Academic, London, pp 1–37
Miller A, Lider O, Weiner HL (1991) Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174:791–798
Neidhart M, Kuchen S, Distler O, Bruhlman P, Michel BA, Gay R, Gay S (1999) Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis Rheum 42:389–392
Overzet K, Gensler TJ, Kim SJ, Geiger ME, van Verooij WJ, Pollard KM, Anderson P, Utz PJ (2000) Small nucleolar RNP scleroderma autoantigens associate with phosphorylated serine/arginine spicing factors during apoptosis. Arthritis Rheum 43:1327–1336
Riente L, Marchini B, Dolcher MP, Puccetti A, Bombardieri S, Migliorini P (1995) Anti-collagen antibodies in systemic sclerosis and primary Raynaud’s phenomenon. Clin Exp Immunol 102(2):354–359
Saito E, Fujimoto M, Hasegawa M, Komura K, Hamaguchi Y, Kaburagi Y, Nagaoka T, Takehara K, Tedder TF, Saito S (2002) CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse. J Clin Invest 109:1453–1462
Sakkas LI, Platsoucas CD (2004) Is systemic sclerosis an antigen-driven T-cell disease? Arthritis Rheum 50(6):1721–1733
Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez SA, Platsoucas CD (2002) Oligoclonal T-cell expression in the skin of patients with systemis sclerosis. J Immunol 168:3649–3659
Sgonc R (1999) the vascular perspectives of systemic sclerosis: of chickens, mice and men. Int Arch Allergy Immunol 120:169–176
Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ (1991) Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon. J Clin Invest 87:1828–1834
Souza RBC, Borges CTL, Capelozzi VL, Carrasco S, Velosa APP, Teodoro WR, Goldenstein-Schainberg C, Yoshinari NH (2005) Abnormal type V collagen deposition in lung fibroblast is correlated with a worse pulmonary capacity in scleroderma (SSc). Arthritis Rheum 52(9):s177
SPSS Statistical software (2002) Version 10.0. SPSS Inc, Chicago
Teodoro WR, Miron BG, Ogido LT, Velosa APP, Abatepaulo F, Capelozzi VL, Yoshinari NH (2003) Synovial remodelling process induced by type V collagen immunization in rabbits. Pathol Res Pract 199:605–612
Teodoro WR, Velosa APP, Witzel SS, Garippo AL, Farhat C, Parra ER, Sonohara S, Capelozzi VL, Yoshinari NH (2004) Architectural remodelling in lungs of rabbits induced by type V collagen immunization: a preliminary morphologic model to study diffuse connective tissue diseases. Pathol Res Pract 200:681–91
Wolfraim LA (2006) Treating autoimmune diseases through restoration of antigen-specific tolerance. Arch Immunol Ther Exp 54:1–13
Xu S-W, Panesar M, Vanchesswaran R, Mason J, Haskard D, Black C et al (1994) Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts: effect of interferon-γ, tumor necrosis factor α, and estrogen. Arthritis Rheum 37:1689–1697
Yamamoto T, Nisshioka K (2005) Cellular and molecular mechanisms of bleomycin-induced murine SSc: current update and future perspective. Exp Dermatol 14:81–95
Yamamoto T, Eckes B, Krieg T. (2001) Effect of interleukin-10 on the gene expression of type I collagen, fobronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-β and monocyte chemoattractant protein-1. Biochem Biophysic Res Comm 281:200–205
Yasufuku K, Heidler KM, O’Donell PW, Cummings OW, Foreman BH, Fujisawa T, Wilkes DS (2001) Oral tolerance induction by type V collagen downregulates lung allograft. Am J Respir Cell Mol Biol 25(1):26–34
Yasufuku K, Heidler KM, Woods KA, Smith GN Jr, Cummings OW, Fujisawa T, Wilkes DS (2002) Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73:500–505
Yoshinari NH, Teodoro WR, Ogido LTI, Velosa APP, Prizon CP, Miron B, Bissoli JCC, Cuentas ERP, Capelozzi VL (2002) Modelo experimental de doenças difusas do tecido conjuntivo (DDTC) induzido por colágeno do tipo V. Rev Bras Reumatol 42:295–305
Yoshinari NH, Callado MR, Velosa APP, Viana VTS, Goldeinstein-Schainberg C, Carrasco S, Bezerra MC, Ogido LT, Oliveira CC, Capelozzi VL, Teodoro WR (2005) Experimental model of scleroderma induced in rabbits. Arthritis Rheum 52(9):s369
Zhang Y, Gilliam AC (2002) Animal models for SSc: an update. Curr Rheumatol Rep 4:150–162
Acknowledgments
This study was supported by the following Brazilian agencies: Foundation for the Support of Research of the State of São Paulo (FAPESP) and Laboratories for Medical Research (LIMs), University Hospital, School of Medicine, University of São Paulo. We thank Cassia Arruda for preparing the skin slides.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP 2000/14336-0, FAPESP 2003/02543-0, 2005/56912-1, CNPq-300430/95-7) and Laboratório de Investigação Médica (Lim 17, Lim 05), School of Medicine, University of São Paulo, Brazil.
Rights and permissions
About this article
Cite this article
Velosa, A.P.P., Teodoro, W.R., de Oliveira, C.C. et al. Collagen V nasal tolerance in experimental model of systemic sclerosis. Arch Dermatol Res 299, 177–189 (2007). https://doi.org/10.1007/s00403-007-0735-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-007-0735-z